Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
Resource Type
Article
Authors
Garcia-Manero, Guillermo ; McCloskey, James ; Griffiths, Elizabeth A ; Yee, Karen W L ; Zeidan, Amer M ; Al-Kali, Aref ; Deeg, H Joachim ; Patel, Prapti A ; Sabloff, Mitchell ; Keating, Mary-Margaret ; Zhu, Nancy ; Gabrail, Nashat Y ; Fazal, Salman ; Maly, Joseph ; Odenike, Olatoyosi ; Kantarjian, Hagop ; DeZern, Amy E ; O’Connell, Casey L ; Roboz, Gail J ; Busque, Lambert ; Buckstein, Rena ; Amin, Harshad ; Randhawa, Jasleen ; Leber, Brian ; Shastri, Aditi ; Dao, Kim-Hien ; Oganesian, Aram ; Hao, Yong ; Keer, Harold N ; Azab, Mohammad ; Savona, Michael R
Source
In The Lancet Haematology January 2024 11(1):e15-e26
Subject
Primary Research Articles
Language
ISSN
2352-3026